Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group | Zendy

Keith C. Bible | Zendy; Gilbert J. Cote | Zendy; Michael J. Demeure | Zendy; Rossella Elisei | Zendy; Sissy Jhiang | Zendy; Matthew D. Ringel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group

Author(s) -

Keith C. Bible,

Gilbert J. Cote,

Michael J. Demeure,

Rossella Elisei,

Sissy Jhiang,

Matthew D. Ringel

Publication year - 2015

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2015-2818

Subject(s) - clinical trial , medicine , thyroid cancer , correlative , population , oncology , family medicine , cancer , philosophy , linguistics , environmental health

Patients with progressive thyroid cancer in distant metastatic sites represent a population with a need for new therapeutic options. Aspiring to improve the treatment of such patients, the objective of this position statement from the International Thyroid Oncology Group (ITOG) is to clarify the importance of incorporating high-quality correlative studies into clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research